Asia Pacific Pharma Sector Analysis - Download this market by variablepitch336

VIEWS: 31 PAGES: 6

									ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Download this market research report on Reportlinker.com

Asia Pacific Pharma Sector Analysis
Published on November 2009

Report Summary
The world continues to witness significant shift in the global pharmaceutical market landscape, with Asia-Pacific emerging as the fastest growing pharmaceutical market over the recent past. With low costs and favorable regulatory environment, the region has seen significant developments in the field of contract manufacturing, particularly in generics and APIs. Several technological advancements have also boosted the R&D activities in the region, helping the market to grow at double digit growth rate in recent years. The size of the Asia-Pacific pharma market is estimated at around US$ 187 Billion for 2009. According to our latest research report 'Asia Pacific Pharma Sector Analysis', the future of pharma industry in the Asia-Pacific region remains bright, and the industry is projected to grow at a CAGR of around 12.6% during 2010-2012. The growth will mainly be driven by low cost factors, changing regulatory environment and increased private sector investments in the industry. Currently, the market is characterized by high growth of generics, and the same trend will continue in near future also. We have found that the region will become the global API production hub in next few years, backed by low cost manufacturing, favorable regulatory environment and current advancements in the production technology. Also, the market will show significant changes in terms of sales and marketing model, which will be changed into tender-based model, favoring the sales of low cost drugs, and thus resulting in intense competition among key players. Our research reveals that the pharma sales are growing rapidly in countries like India, China, Malaysia, South Korea and Indonesia. This growth is mainly attributed to the increase in disposable income along with the emergence of several health insurance schemes, which are giving a boost to the sales of branded drugs. Besides this, the intense competition among key players in the region has been easing the availability of low cost drugs, thus providing a further boost to the market growth. Our report provides an extensive and objective analysis on the Asia-Pacific pharma market. It provides analytical and statistical information on regional level markets, including their market size and segmentation. It also features an analysis on the future directions, supplemented with various facts and figures. Thus, the report serves as a useful guide for pharmaceutical companies, government officials, consultants and investors who are planning to enter the Asia-Pacific pharma market.

Table of Content
1. Analyst View 2. Global Pharmaceutical Market Overview 2.1 Market Size and Growth 2.2 Leading Drugs 3. Asia-Pacific Pharmaceutical Market Overview 4. Pharmaceutical Market By Country 4.1 China 4.1.1 Market Overview 4.1.2 Future Outlook 4.1.3 Regulatory Environment

Asia Pacific Pharma Sector Analysis

Page 1/6

ReportLinker
4.2 India 4.2.1 Market Overview 4.2.2 Future Outlook 4.2.3 Regulatory Environment 4.3 Japan 4.3.1 Market Overview 4.3.2 Future Outlook 4.3.3 Regulatory Environment 4.4 South Korea 4.4.1 Market Overview 4.4.2 Future Outlook 4.4.3 Regulatory Environment 4.5 Indonesia 4.5.1 Market Overview 4.5.2 Future Outlook 4.5.3 Regulatory Environment 4.6 Vietnam 4.6.1 Market Overview 4.6.2 Future Outlook 4.6.3 Regulatory Environment 4.7 Thailand 4.7.1 Market Overview 4.7.2 Future Outlook 4.7.3 Regulatory Environment 4.8 Philippines 4.8.1 Market Overview 4.8.2 Future Outlook 4.8.3 Regulatory Environment 4.9 Malaysia 4.9.1 Market Overview 4.9.2 Future Outlook 4.9.3 Regulatory Environment 4.10 Australia 4.10.1 Market Overview 4.10.2 Future Outlook 4.10.3 Regulatory Environment 4.11 New Zealand 4.11.1 Market Overview 4.11.2 Future Outlook 4.11.3 Regulatory Environment 5. Emerging Market Trends 5.1 Contract Manufacturing 5.2 Vaccine Market 5.3 Generics 5.4 Medical Tourism Market 6. Industry Restraints and Recommendation 6.1 IPR Protection 6.2 Regulatory Issues 6.3 Reimbursement Issues 6.4 Low Investments in R&D

Find Industry reports, Company profiles and Market Statistics

Asia Pacific Pharma Sector Analysis

Page 2/6

ReportLinker
7. Competitive Landscape 7.1 GlaxoSmithKline plc 7.2 Pfizer Inc 7.3 Sanofi-Aventis 7.4 Ranbaxy Laboratories Limited 7.5 Takeda Pharmaceutical Company Limited List of Figures: Figure 2-1: Global - Pharmaceutical Market (Billion US$), 2004-2009 Figure 2-2: Global - Growth in Pharmaceutical Market (%), 2004-2008

Find Industry reports, Company profiles and Market Statistics

Figure 2-3: Global - Forecast for Pharmaceutical Market (Billion US$), 2010-2012 Figure 3-1: Asia-Pacific - Pharmaceutical Market (Billion US$), 2007-2009 Figure 3-2: Asia-Pacific - Pharmaceutical Market by Country (%), 2008 Figure 3-3: Asia-Pacific - Forecast for Pharmaceutical Market (Billion US$), 2010-2012 Figure 3-4: Asia-Pacific - Forecast for Pharmaceutical Market by Country (%), 2012 Figure 4-1: China - Pharmaceutical Market (Billion US$), 2007-2009 Figure 4-2: China - Share of Imported and Domestically Manufactured Drugs in Pharma Market (2008) Figure 4-3: China - Share of Generic Drugs in Pharma Market (2008) Figure 4-4: China - Forecast for Pharmaceutical Market (Billion US$), 2010-2012 Figure 4-5: India - Pharmaceutical Market (Billion US$), 2007-2009 Figure 4-6: India - Pharmaceutical Exports (Billion INR), 2007-08 & 2008-09 Figure 4-7: India - Forecast for Pharmaceutical Market (Billion US$), 2010-2012 Figure 4-8: Japan - Pharmaceutical Market (Billion US$), 2007-2009 Figure 4-9: Japan - Share of Imported and Domestically Manufactured Drugs in Pharma Market (2008) Figure 4-10: Japan - Share of Generics and Branded Drugs in Pharma Market (2008) Figure 4-11: Japan - Forecast for Pharmaceutical Market (Billion US$), 2010-2012 Figure 4-12: South Korea - Pharmaceutical Market (Billion US$), 2007-2009 Figure 4-13: South Korea - Share of OTC and Prescription Drugs in Pharma Market (2008) Figure 4-14: South Korea - Share of Generics and Branded Drugs in Pharma Market (2008) Figure 4-15: South Korea - Forecast for Pharmaceutical Market (Billion US$), 2010-2012 Figure 4-16: Indonesia - Pharmaceutical Market (Trillion Rp), 2007-2009 Figure 4-17: Indonesia - Share of OTC and Prescription Drugs in Pharma Market (2008) Figure 4-18: Indonesia - Share of Generics and Branded Drugs in Pharma Market (2008) Figure 4-19: Indonesia - Forecast for Pharmaceutical Market (Trillion Rp), 2010-2012 Figure 4-20: Vietnam - Pharmaceutical Market (Billion US$), 2007-2009 Figure 4-21: Vietnam - Share of Imported and Domestically Manufactured Drugs in Pharma Market (2008) Figure 4-22: Vietnam - Share of Generics and Branded Drugs in Pharma Market (2008) Figure 4-23: Vietnam - Forecast for Pharmaceutical Market (Billion US$), 2010-2012 Figure 4-24: Thailand - Pharmaceutical Market (Billion THB), 2007-2009 Figure 4-25: Thailand - Share of Imported and Domestically Manufactured Drugs in Pharma Market (2008) Figure 4-26: Thailand - Share of Branded and Generics Drugs in Pharma Market (2008) Figure 4-27: Thailand - Forecast for Pharmaceutical Market (Billion THB), 2010-2012 Figure 4-28: Philippines - Pharmaceutical Market (Billion PHP), 2007-2009 Figure 4-29: Philippines - Share of OTC, Prescription & Nutritional Drugs in Pharma Market (2008) Figure 4-30: Philippines - Market Structure of the Pharmaceutical Industry Figure 4-31: Philippines - Share of Foreign and Domestic Firms in Pharma Market (2008) Figure 4-32: Philippines - Forecast for Pharmaceutical Market (Billion PHP), 2010-2012 Figure 4-33: Malaysia - Pharmaceutical Market (Million US$), 2007-2009 Figure 4-34: Malaysia - Share of Generics and Branded Drugs in Pharma Market (2008)

Asia Pacific Pharma Sector Analysis

Page 3/6

ReportLinker

Find Industry reports, Company profiles and Market Statistics

Figure 4-35: Malaysia - Share of Imported and Domestically Manufactured Drugs in Pharma Market (2008) Figure 4-36: Malaysia - Forecast for Pharmaceutical Market (Million US$), 2010-2012 Figure 4-37: Australia - Pharmaceutical Market (Billion US$), 2007-2009 Figure 4-38: Australia - Share of Generics and Branded Drugs in Pharma Market (2008) Figure 4-39: Australia - Pharmaceutical Export by Destination (%), 2006 Figure 4-40: Australia - Forecast for Pharmaceutical Market (Billion US$), 2010-2012 Figure 4-41: New Zealand - Pharmaceutical Market (Billion US$), 2007-2009 Figure 4-42: New Zealand - Forecast for Pharmaceutical Market (Billion US$), 2010-2012 Figure 5-1: Global - Pharmaceutical Contract Manufacturing Market (Billion US$), 2008-2012 Figure 5-2: Asia-Pacific - Generics Market (Billion US$), 2007-2009 Figure 5-3: Asia - Medical Tourism Market (Billion US$), 2007-2009 Lists of Tables: Table 2-1: Global - Leading Drugs by Sales (Billion US$), 2008 Table 4-1: China - Healthcare Statistics (2007-2009) Table 4-2: China - Timeframe for New Drug Review Table 4-3: India - Healthcare Statistics (2007-2009) Table 4-4: Japan - Healthcare Statistics (2007-2009) Table 4-5: South Korea - Healthcare Statistics (2007-2009) Table 4-6: Indonesia - Healthcare Statistics (2007-2009) Table 4-7: Vietnam - Healthcare Statistics (2007-2009) Table 4-8: Thailand - Healthcare Statistics (2007-2009) Table 4-9: Philippines - Healthcare Statistics (2007-2009) Table 4-10: Malaysia - Healthcare Statistics (2007-2009) Table 4-11: Australia - Healthcare Statistics (2007-2009) Table 4-12: New Zealand - Healthcare Statistics (2007-2009) Table 7-1: GlaxoSmithKline plc - Strengths & Weaknesses Table 7-2: Pfizer Inc - Strengths & Weaknesses Table 7-3: Sanofi-Aventis - Strengths & Weaknesses Table 7-4: Ranbaxy Laboratories Limited - Strengths & Weaknesses Table 7-5: Takeda Pharmaceutical - Strengths & Weaknesses

Asia Pacific Pharma Sector Analysis

Page 4/6

ReportLinker
Fax Order Form

Find Industry reports, Company profiles and Market Statistics

To place an order via fax simply print this form, fill in the information below and fax the completed form to . If you have any questions please visit http://www.reportlinker.com/notify/contact (805) 617 17 93

Order Information
Please verify that the product information is correct and select the format(s) you require.
Asia Pacific Pharma Sector Analysis

Product Formats
Please select the product formats and the quantity you require.
1 User License--USD 1 050.00 Quantity: _____

Hard Copy--USD 1 225.00

Quantity: _____

CD-ROM--USD 1 225.00

Quantity: _____

Site License--USD 1 750.00

Quantity: _____

Contact Information
Please enter all the information below in BLOCK CAPITALS

Title: First Name: Email Address: Job Title: Organization: Address: City:

Mr

Mrs

Dr

Miss

Ms

Prof

_____________________________ Last Name: __________________________________ __________________________________________________________________________ __________________________________________________________________________ __________________________________________________________________________ __________________________________________________________________________ __________________________________________________________________________ __________________________________________________________________________ __________________________________________________________________________ __________________________________________________________________________ __________________________________________________________________________

Postal / Zip Code: Country: Phone Number: Fax Number:

Asia Pacific Pharma Sector Analysis

Page 5/6

ReportLinker
Payment Information

Find Industry reports, Company profiles and Market Statistics

Please indicate the payment method, you would like to use by selecting the appropriate box.

Payment by credit card

Card Number: ______________________________________________

Expiry Date

__________ / _________

CVV Number _____________________

Card Type (ex: Visa, Amex…) _________________________________

Payment by wire transfer

Crédit Mutuel RIB : 10278 07314 00020257701 78 BIC : CMCIFR2A IBAN : FR76 1027 8073 1400 0202 5770 178

Payment by check

UBIQUICK SAS 16 rue Grenette – 69002 LYON, FRANCE

Customer signature:

 

Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at http://www.reportlinker.com/index/terms

Please fax this form to

(805) 617 17 93

Asia Pacific Pharma Sector Analysis

Page 6/6


								
To top